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Summary
Introduction: Intra-articular corticosteroids are widely used as anti-inflammatory agents for symptomatic management
of arthritis, but their administration with concurrent exercise remains controversial. Biochemical and morphologic
analysis of treated cartilage has revealed conflicting results, but previous biomechanical assessment has not been
undertaken.
Objective: To compare the biomechanical properties of intra-articular methylprednisolone acetate (MPA) and
diluent treated cartilage in treadmill exercised horses.
Methods: Eight 2-year-old female horses had MPA or diluent administered into contralateral middle carpal joints
at 14 day intervals for a total of four treatments per horse. Horses underwent a standard treadmill exercise protocol
until euthanasia (day 70). Standard sites were tested on the third, radial and intermediate carpal bones using an
automated indentation apparatus to obtain the creep and recovery behavior of the articular cartilage. Using previously
validated biphasic creep indentation methodology, aggregate modulus, Poisson’s ratio, permeability, shear modulus,
thickness, creep and recovery equilibrium times and percent recovery were obtained at each site. Results were analyzed
using ANOVA and multiple comparisons of the means (P Q 0.05).
Results: Cartilage intrinsic material properties and thickness demonstrated significant differences between MPA and
diluent treated joints. Diluent treated cartilage had a 97% increase in compressive stiffness modulus (P = 0.0001), was
121% more permeable (P = 0.0001), had 88% increase in shear modulus (P = 0.0001), and was 24% thicker (P = 0.0001)
than MPA treated articular cartilage.
Conclusions: The findings indicate that repetitive intra-articular administration of MPA to exercising horses alters
the mechanical integrity of articular cartilage, which could lead to early cartilage degeneration.
Keywords: Equine, Articular cartilage, Biomechanics, Cartilage material properties.
Introduction
Intra-articular and systemic corticosteroids are
widely used in human and veterinary medicine for
their potent anti-inflammatory effects. Symp-
tomatic benefit from corticosteroid injections in
human osteoarthritic joints has frequently been
reported [1]. In the equine athlete, corticosteroids
administered by the intra-articular route have
achieved particular popularity, which may relate
to the tendency for only a single or few joints to be
affected, the frequent requirement for a rapid
return to athletic function, and the adverse effects
of systemic corticosteroids. However, the use of
intra-articular corticosteroids in association with
exercise remains controversial in both human and
veterinary medical literature [1, 2]. Although
intra-articular corticosteroids have been shown to
have beneficial effects in some conditions [3, 4],
long-term detrimental consequences on the articu-
lar cartilage and soft tissue structures have been
demonstrated experimentally [5, 6], and clinically
steroid-induced arthropathy has been reported [7].
Previous investigation into the effects of
intra-articular corticosteroids have been limited to
the effects on cartilage healing, histologic and
biochemical evaluation [8, 9]. There are no reports
of the effects of intra-articular corticosteroids on
biomechanical properties, although mechanical
behaviour is fundamental for the competence of
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articular cartilage. Disparity in the compressive
modulus of opposing articular surfaces has been
associated with areas of cartilage abrasion and
degeneration in humans [10–12]. Differences in
compressive properties have been noted between
normal and osteoarthritic articular cartilage
[10, 12].
Joint deterioration following intra-articular
corticosteroid administration was attributed in-
itially to a local relief from pain resulting in
increased joint stress without resolution of any
articular cartilage or subchondral bone damage
[13]. Studies in exercised horses have shown
increasing joint damage when intra-articular
corticosteroids were administered following osteo-
chondral fracture trauma [14, 15]. In these reports
methylprednisolone acetate (MPA) administration
in one normal, exercised joint did not lead to
significant detrimental findings. Rest after intra-
articular corticosteroid therapy is recommended to
prevent excessive wear resulting from increased
mobility in the presence of potentially compro-
mised cartilage status. However there have been
few controlled investigations into the issue of
post-injection exercise [2].
At high doses, corticosteroids have been re-
ported to reduce chondrocyte metabolism by
decreased matrix synthesis and chondrocyte
proliferation [16, 17]. The deleterious effects of
intra-articular MPA that have been reported in
horses include chondrocyte necrosis, decreased
proteoglycan synthesis and content, decreased
collagen synthesis by chondrocytes, decreased
collagen cross-linking and an increased cartilage
matrix water content [7, 18, 19]. Repeated adminis-
tration of MPA in the non-exercised horse did not
result in clinical lameness or detectable radio-
graphic lesions [19]. Histological and biochemical
evaluation revealed a significant reduction in
proteoglycan and collagen levels in the articular
cartilage matrix [18, 19].
A protective action of corticosteroids on carti-
lage has been shown in rabbits where there was
limited joint mobility and poor synovial fluid
quality [20]. In dogs corticosteroids have been
found to be effective against the development of
osteoarthritic lesions in an unstable joint model
[3]. In vitro hydrocortisone has been shown to
reduce cartilage proteoglycan breakdown
[4, 7, 21, 22]. Glucocorticoids have been demon-
strated to suppress metalloprotease synthesis in
vitro and in vivo, thereby preventing cartilage
matrix degradation [13, 23, 24].
The equine middle carpal joint is a site
frequently affected by osteochondral damage and
subsequent osteoarthritis, particularly in the
immature athlete [5]. Examination of the bio-
mechanical properties of equine middle carpal
articular cartilage has demonstrated topographi-
cal variations which support clinical observation
of sites of cartilage damage [25]. Evaluation of the
effects of MPA and exercise on the mechanical
behaviour of normal articular cartilage are
necessary to increase our understanding before
assessment of damaged joints, where experimental
conditions could be altered by natural disease
progression. The objectives of this study were
therefore to: (1) determine the intrinsic bio-
mechanical properties of equine middle carpal
articular cartilage after treatment with multiple
administrations of MPA while on a standardized
regimen of treadmill exercise, and (2) compare
these properties with those of the contralateral
middle carpal articular cartilage after repeated
intra-articular administration of diluent solution,
using an automated creep indentation apparatus.
Materials and Methods
Eight, 2-year-old, female quarter horses were
selected for study on the basis of an absence of
lameness, effusion or pain on carpal flexion, and
normal carpal radiographic findings. Each horse
was vaccinated against tetanus, Eastern equine
encephalitis, Western equine encephalitis and
influenza, and was dewormed as needed. Nutri-
tional status was maintained by feeding 3% body
weight dry matter. All horses were maintained on
pasture over the 70-day period of the study.
At the start of the study each horse underwent
bilateral middle carpal intra-articular injection.
This procedure was repeated at 14 day intervals for
a total of four treatments in each carpus per horse.
Each horse was sedated with at least 0.5 mg/kg of
xylazine hydrochloride before treatment. The skin
over the carpal joints of each horse was clipped
and aseptically prepared. One hundred milligram
(2.5 ml) of MPA (Depo Medrol, 40 mg/ml. The
Upjohn Company, Kalamazoo, MI, U.S.A.) was
injected into a randomly selected middle carpal
joint using a 0.8 mm × 25 mm needle, placed
between the tendons of the extensor carpi radialis
and common digital extensor muscles. In four
horses the left carpus was treated with MPA, and
in four horses the right carpus was treated with
MPA. A 2.5 ml volume of diluent solution (pH
adjusted polyethylene glycol, sodium chloride and
myristyl-gamma-picolinium chloride) was injected
into the contralateral middle carpal joint which
served as an injected control. The diluent solution
had identical composition to the MPA solution
excluding the corticosteroid component.
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Throughout the duration of the experiment each
horse was exercised using a Sato 1 high speed
treadmill. Before commencement of the study,
experimental horses were acclimated to the
treadmill and underwent early endurance training,
comprising a 3-week period of gradually increasing
exercise duration from 3.5 to 8 m/s. Throughout the
investigation a standard exercise protocol was
undertaken which incorporated endurance and
speed training. For all 10 weeks of the study a
3000 m exercise protocol was performed 3 days per
week; weeks 1–2, 1700 m at 3.5 m/s and 1300 m at
8 m/s, weeks 3–5 1500 m at 3.5 m/s and 1500 m at
8 m/s, weeks 6–10 1000 m at 3.5 m/s and 2000 m at
8 m/s. From week 3 ‘breeze’ work for 800 m was
introduced at 12–13 m/s to simulate race training
speeds. At weekly intervals the distance was
increased by 200 m to a maximum of 2000 m
performed at each session. ‘Breeze’ work was
performed at 7-day intervals, as a fair represen-
tation of a normal schedule for a horse in training
[26, 27]. This exercise routine was continued for
the 70-day period following the initial intra-
articular injection. Throughout the 70 days of the
study, each horse was assessed daily for evidence
of lameness or joint effusion. Body temperature,
pulse and respiratory rates were determined and
recorded daily. Each horse underwent this stan-
dard treadmill exercise protocol until 3 days prior
to euthanasia by lethal injection of barbiturate on
day 70.
Carpi were collected immediately after death
and dissected to reveal the articular surfaces.
Standard test sites were identified using measure-
ment with calipers at axial and abaxial locations
on the dorsal aspects of the radial and intermedi-
ate facets of the third carpal bone. Sites were
selected on the distal radial and intermediate
carpal bones which corresponded with the selected
locations on the third carpal bone. Eight sites were
identified per joint (Fig. 1): Radial axial (RRX);
radial abaxial (RRY); intermediate axial (IIX);
intermediate abaxial (IIY); third carpal medial
facet axial (3MX); medial facet abaxial (3MY);
lateral facet axial (3LX); lateral facet abaxial
(3LY). The specimens were wrapped in gauze
soaked in Ringer’s solution and stored at −80°C.
All mechanical testing was performed at the
University of Texas Health Science Center at San
Antonio. At the time of indentation testing, each
frozen specimen was thawed at room temperature
for 1 h in normal saline (0.1 m NaCl) containing
protease inhibitors (N-ethyl malemide, 10 mm;
benzamidine HCl, 5 mm; EDTA, 2 mm; and PMSF,
1 mm). Each osteochondral specimen from the
midcarpal joint was sectioned horizontally leaving
Fig. 1. Topographical map of the equine middle carpal
joint identifying the test sites on each articular surface.
RRX = distal radial carpal articular surface, axial site;
RRY = distal radial carpal articular surface, abaxial site;
IIX = distal intermediate carpal articular surface, axial
site; IIY = distal intermediate carpal articular surface,
abaxial site; 3MX = proximal third carpal articular
surface, medial facet, axial site; 3MY = proximal third
carpal articular surface, medial facet, abaxial site;
3LX = proximal third carpal articular surface, lateral
facet, axial site; 3LY = proximal third carpal articular
surface, lateral facet, abaxial site.
the articular surface intact. All osteochondral
specimens were at least 25 mm × 25 mm. The
osteochondral specimens were tested using an
automated creep indentation apparatus (friction
Q9.81 × 10 − 4 N) [25]. The specimen was mounted
with cyanoacrylate cement onto an aluminum base
plate. A fiberoptic positioning system, in-line with
the loading shaft, was used for verifying that load
shaft was perpendicular to the test point on the
articular surface. A porous, rigid, cylindrical
indenter tip of 0.5 mm in diameter was used to
apply a step load of 0.039 N normal to the central
portion of the testing point. Thickness measure-
ments were performed with a needle probe system
[10–12, 25].
The tissue’s material properties, as described by
the linear biphasic theory [28–30], are the aggre-
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gate modulus (HA in MPa), which is the tissue’s
compressive stiffness modulus, the Poisson’s ratio
(ns), which represents the tissue’s apparent com-
pressibility, the shear modulus (m in MPa), and
permeability (k in m4/Ns), which is indicative of
the tissue’s interstitial fluid flow inside the pores
of articular cartilage. A solution scheme [10, 11]
based on biphasic finite element analysis [31] and
non-linear optimization techniques [32] was used.
For the sake of completeness, a brief description of
this solution scheme follows: Each osteochondral
specimen was modelled as an axisymmetric
cylinder of uniform depth of a linear biphasic
material [29], with unknown properties K1, where,
Ki = [HiA, nis, ki]T. The central region of the cartilage
layer was subjected to a step load P(t) = PoH(t)
through a frictional, rigid, porous, permeable,
cylindrical indenter [10–12, 25, 33]. Each finite
element mesh was automatically generated for
each specimen by specifying the tip radius,
specimen thickness, and test load. The experimen-
tally obtained temporal variations of the solid
axial displacement (Ue) were used to solve this
creep problem with a finite element formulation
[31]. Numerical curvefit was provided by an
optimization technique [32]. The objective of the
optimization technique was to obtain the unknown
vector K1. The code consisted of the main program,
the finite element subroutine and the optimization
subprograms—obtained from the ADS library [33].
Before running the finite element-optimization
routine, each creep test was solved using the
biphasic creep indentation methodology [28, 29].
This solution represented the initial guess (Ko1),
which was necessary to initiate the optimization
routine. In the main program, we read Ue,
introduced the initial guess (Ko1), applied the finite
element solution, postprocessed the solid axial
displacement (Ut), set up and calculated the
objective function F(K1) = S (Ue − Ut)2, and applied
the optimization procedure to minimize F(K1). This
iterative procedure was executed on an HP900 (730
series) workstation. The entire creep curve was
used for obtaining the biomechanical properties of
each specimen [10–12, 28–33].
Analysis of variance (ANOVA) procedures were
performed to study the following independent
factors: horse, side (right; left), carpal bone (radial;
intermediate; medial and lateral facets of third),
location (axial; abaxial); and treatment of tissue
(MPA; diluent) on the dependent variables (aggre-
gate modulus—HA; Poisson’s ratio—ns; permeabil-
ity—k; thickness—h; shear modulus—m).
Student’s t-test comparison of the means was
applied when the F test in the ANOVA was
significant, to test for differences in site-specific
variables. The statistical significance was set at
P Q 0.05 for all tests.
Results
clinical evaluation
There was no evidence of lameness or pain on
carpal flexion in any of the horses during the
period of the investigation. Mild effusion was
present in the injected control carpi of horses 1 and
2 following the second intra-articular adminis-
tration of diluent solution which was not associ-
ated with lameness and resolved within 3 days. The
carpal effusion was observed to recur in horse 1
following the third injection, but subsequently
resolved. Pain on palpation was noted to be absent
on all days that intra-articular injections were not
performed.
cartilage gross evaluation
Macroscopic evaluation of the articular surfaces
and surrounding soft tissues of the middle carpal
joint revealed a normal appearance. No differences
were observed between the MPA and diluent
treated joints.
cartilage biomechanical behavior
Using ANOVA procedures, statistically signifi-
cant differences were observed in the material
properties and thickness between MPA and
diluent treated carpi (P Q 0.00001 for all proper-
ties). Some variability was observed between
horses, but no significant effect of side (left; right),
carpal bone (radial; intermediate; third) or lo-
cation (axial; abaxial) was observed (P q 0.05). The
intrinsic material properties (HA, ns, k, m) and
thickness (h) of articular cartilage of the middle
carpal joint for MPA and diluent treated carpi are
given in Table I showing mean 2 s.d. Results are
given individually for each site and for all sites
grouped together.
For all sites grouped together, the results
indicate that diluent treated tissue is less
compressible, has a 97.1% larger compressive
modulus (P = 0.0001), is 120.7% more permeable
(P = 0.0001), has an 88.2% larger shear modulus
(P = 0.0001), and is 24.3% thicker (P = 0.0001) than
tissue treated with MPA. Significant differences
were also found between MPA and diluent treated
cartilage for individual test sites.
The intrinsic material properties and thickness
of the cartilage within the diluent treated group
did not differ between test sites. Similarly no
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topographical differences were observed within
the MPA-treated group.
Discussion
It has been stated that corticosteroids have no
significant long-term effects on cartilage [2, 34].
However, 21 days after a series of four intra-
articular injections of MPA in exercised horses,
the cartilage was thinner, more compressible and
less stiff than diluent treated. Cartilage with these
altered mechanical properties may develop lesions
which could result in long-term detriment to the
patient. It has been shown that alterations in the
biochemical composition associated with degener-
ation of articular cartilage correspond to a loss in
stiffness, strength and other functional properties
[35–37], so it has been considered reasonable to
correlate aggregate modulus with the cartilage
structural integrity [10]. The softer cartilage would
experience more strain than normal cartilage with
a similar stress, and may therefore be unable to
withstand the repetitive loading of exercise. The
low stiffness and high compressibility of the
MPA-treated cartilage indicate that it has a slower
creep and equilibration than diluent-treated carti-
lage [10]. The horses in this study were subjected
to a standard exercise regimen and did not develop
any grossly or clinically apparent osteochondral
lesions. However the cartilage mechanical proper-
ties could be considered ‘inferior’ [10], and it is
possible that more rigorous exercise could result in
gross damage. There is debate about whether
joints should be rested after intra-articular
injection of corticosteroids [2]. Based on the
results of this study, by exercising following
intra-articular corticosteroid injection it may pre-
dispose the cartilage to develop lesions. The test
sites selected were all sites with high incidence of
osteochondral lesions, which accentuates the
clinical relevance of the findings [25, 38, 39]. Based
on the results of this study we would not
recommend exercising horses vigorously for a
period of at least 27 days (interval between the last
injection and euthanasia for this study) following
a series of intra-articular injections of MPA.
Although the material properties of MPA-
treated, exercised cartilage were altered compared
to diluent treated, they did not mimic exactly those
of osteoarthritis. Exercised MPA-treated cartilage
was softer and thinner, and thus similar to
osteoarthritic cartilage [35]. However, in contrast
to the increased permeability of osteoarthritic
cartilage, the permeability of MPA-treated carti-
lage was lower than diluent-treated cartilage. It
would be expected that the mechanical behavior of
osteoarthritic and MPA-treated cartilage would
differ if there is a difference in tissue composition.
It has been previously reported that although
proteoglycans are depleted and water content is
increased similar to MPA-treated, exercised carti-
lage, fibronectin is increased in osteoarthritic
cartilage [40, 41]. However, it has been suggested
that fibronectin content may be decreased in MPA
treated cartilage [19]. These reports of compo-
sitional alterations could be supported by the
mechanical differences observed in this study.
Cartilage stiffness has been related to proteo-
glycan content [33]. The results of the present study
revealed a reduced stiffness (decrease in HA) in the
MPA-treated cartilage at 3 weeks following the
series of four injections which would support the
reduction in proteoglycan content in the MPA-
treated articular cartilage reported by Trotter [19].
In that study examination of the cartilage from the
middle carpal joint of horses 3 weeks after a series
of three repeated injections of MPA at the same
intervals as the present study revealed a reduction
in proteoglycan and collagen content, but no
evidence of degenerative changes in chondrocytes
[19]. It has been shown that equine chondrocytes in
normal joints appear to be regaining their ability
to synthesise proteoglycans at 21 days after
administration of MPA, but have not yet been able
to return the proteoglycan content to a normal
level [42]. A reduction in overall proteoglycan
content or an alteration in specific proteoglycans
would be supported by the reduction in cartilage
stiffness demonstrated in this study.
The dose of MPA selected for this study was
considered to be within the range of a typical
clinical dose used for the equine middle carpal
joint, and was also comparable to that used in
human joints. It is also consistent with previous
studies of low-dose intra-articular corticosteroid
administration in other animals [14, 34, 43, 44].
High doses of corticosteroids have been reported to
cause damage to articular surfaces [43]. Lower
doses used clinically have not been correlated with
gross lesions in normal joints. The results of our
study indicated an alteration in mechanical
properties at the dose used. It has been shown in
vitro that a low concentration of glucocorticoid
inhibited matrix metalloprotease activity and
proteoglycan catabolism, but had minimal effect
on the suppression of proteoglycan synthesis [23].
If this dose of corticosteroid is ascertained in vivo,
then it may be possible to eliminate the deterio-
ration in cartilage mechanical properties that was
seen in this study. It must be noted that in this
study the effect on cartilage material properties in
a damaged joint have not been determined.
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In contrast to previous studies on the effects of
intra-articular MPA, all experimental horses were
of the same age, breed and sex which eliminated
these factors between horses. MPA has been shown
to produce different degrees of proteoglycan
depletion in ponies of varying ages, with younger
ponies being more responsive to proteoglycan
depletion [42]. The age of horses selected for use in
this study was based on the age of many racing
horses, in which corticosteroids are commonly
administered by intra-articular injection. Normal
joints were considered to constitute a better
control for experimental study than damaged
joints, where it would be impossible to determine
how the results are influenced by natural
progression of the disease.
The pharmacological effect of corticosteroids
may last longer than their direct effects in a joint
as a result of decreased synthesis of proteoglycans
and proteases. Clinical improvement is reported to
last for a longer duration than the corticosteroid
is present within the synovial fluid [13]. Following
MPA injection in equine joints, MPA or methyl-
prednisolone have been found to persist within the
synovial fluid for 2–39 days [45]. Cartilage levels
have not been determined and could be maintained
longer for a longer period. Repeated intra-articular
administration of corticosteroid may therefore be
additive in effects. It has been noted that multiple
glucocorticoid injections may cause a progressive
destruction of the articular surfaces with minimal
clinical signs [46]. The results of this study do
demonstrate detrimental changes in the cartilage
biomechanical behavior following a series of
intra-articular injections of MPA at 14 day
intervals in association with exercise. The study
was limited to the effects of multiple injections,
and so the effects of a single MPA injection on
mechanical behavior has not been evaluated.
The contralateral limb was considered to be a
valid control as it has been shown that only trace
concentrations of methylprednisolone are found in
equine plasma following intra-articular adminis-
tration of 111 mg MPA [46], no MPA was detected
in the contralateral limb synovial fluid following
intra-articular administration of 100 mg MPA [47],
and has been used as a control for previous studies
[9, 19]. It is certainly possible that there may be a
remote effect of MPA on the contralateral limb.
However, a remote effect would be expected to
reduce the differences between the MPA and
diluent treated joints, therefore potentially in-
creasing the significance of the findings. The
biomechanical properties of the cartilage from
diluent treated joints were similar to the mechan-
ical properties of cartilage from non-injected
equine middle carpal joints in nonexercised horses,
reported previously from comparable locations
[25]. Differences observed in cartilage permeability
between the diluent treated, exercised cartilage
and the untreated, nonexercised cartilage may be
related to the effect of exercise, as it has been
shown that exercise may lead to increased
cartilage permeability in the equine third carpal
bone [48].
Biomechanical testing demonstrated that intrin-
sic material properties are significantly different
between MPA and diluent treated cartilage
indicating that MPA treated cartilage in treadmill
exercised horses has altered mechanical behavior.
These findings suggest that repetitive intra-articu-
lar administration of MPA to exercising horses
may affect the structural integrity of the articular
cartilage. Compromise in cartilage integrity could
potentially lead to early degenerative changes,
suggesting that any short-term benefits obtained
by repetitive use of corticosteroids in joints
without pathology may be outweighed by long-
term detrimental effects on the cartilage.
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